Navigation Links
Embolic Protection Devices (EPD) - Emerging Markets 2009-2015
Date:11/7/2013

DUBLIN, Ireland, November 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qfnpf3/embolic) has announced the addition of the "Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015" report to their offering.

BRICSS EP Devices market forecasts to reach at US$93.3 million by 2015 at a CAGR of 15.6% during the analysis period 2009-2015. China accounts for nearly 30% of the global value and India claims around 20% of the market. In terms of CAGR, India is the fastest growing regions while China, South Korea and Russia are just behind. Forecasts for balloon occlusion types indicate a close 47% of the market value while catheters occlusion devices account for nearly 40%. In case of procedures, coronary sector depicts the largest CAGR while peripheral artery and neurology segments come in second and third place respectively.

Publication Overview

The report Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in the EPD market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufa
'/>"/>

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
2. InspireMDs MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
3. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
4. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
5. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
6. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
7. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
8. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
9. TSI Respiratory Protection Roadshow Rated Top-Notch By Attendees
10. Sanarias Malaria Vaccine Yields Unprecedented Protection In Phase 1 Clinical Trial
11. iBio Obtains New IP Protection in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... DUBLIN and RALEIGH, N.C. ... subsidiary of Endo International plc (NASDAQ: ENDP ... BDSI ) announced today that they have ... Buccal Film to the U.S. Food and Drug Administration ... the management of pain severe enough to require daily, ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... "US Self-monitoring Blood Glucose Market" report to ... This market insight focuses on the developments ... the United States . Reimbursement analysis and the ... analyses for more than 73 SMBG meters have been ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2
...   Syndax Pharmaceuticals, Inc ., a clinical-stage epigenetics oncology ... 2 clinical trials with entinostat in combination and as ... conferences.  San Antonio Breast Cancer ... randomized, double-blind, placebo-controlled, phase 2 study of exemestane with ...
...  Henry Schein, Inc., (NASDAQ: HSIC ), the ... office-based practitioners, announced today that Stanley Bergman, Chairman and ... the Company,s Executive Vice President and Chief Financial Officer, ... on December 6.  The conference is being held at ...
Cached Medicine Technology:Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 2Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 3Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 4Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 5Henry Schein to Present at the NASDAQ OMX 27th Investor Program 2
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... of youth" drug that can delay the effects of aging ... suggests. Seniors received a significant boost to their immune ... pathway linked to aging and immune function, researchers with the ... a version of the drug rapamycin, improved the seniors, immune ...
(Date:12/25/2014)... Aliso Viejo, California (PRWEB) December 25, 2014 ... the release of ProFire 5k. A fully customizable business ... X . , “Adding the ProFire 5k business tool, ... style” Said Christina Austin, CEO of Pixel Film Studios. ... the look and style to add professionalism to a ...
(Date:12/24/2014)... December 25, 2014 AlignLife of Wauwatosa ... to afford certain items. During the holiday season, AlignLife looks ... over 70 toys," says Dr. Sara Mahalko-Leonhardt, owner of AlignLife. ... such joy, knowing that we are able to give kids ... it not been for the generosity of our patients." , ...
(Date:12/24/2014)... a famous dress manufacturer and retailer, has announced its ... items are brand new; they are made by experienced designers. ... new range of high quality prom gowns. A lot of ... made according to the latest trends. For years, the supplier ... company is handpicked by skilled tailors. , In the comments ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 ... ) that allege the blood thinner caused life-threatening ... outlined a leadership structure for the proceeding, Bernstein ... December 17th, the Court plans to select lawyers ... and also plans on appointing a Plaintiffs’ Steering ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... Hematopoietic stem cell transplantation (HSCT) and associated immunosuppression ... infections (IFIs). IFIs are a significant cause of morbidity ... epidemiology of IFIs have led to an increased frequency ... are linked to poor outcomes in patients. It is ...
... National Awareness Campaign to Combat Breast Cancer has ... Cancer Awareness month. The campaign is led by Princess Hessah bint ... and wife of the Custodian of the Two Holy ... Abdullah bin Abdulaziz. It officially launched on October 10. , ...
... - A study published in the October issue of ... tumor-suppressor protein p53, coupled with elimination of the DNA-maintenance ... a result, tissues deteriorate rapidly, which is generally fatal ... evidence for the use of inhibitors of ATR in ...
... to prevent fever at shot time could be counterproductive, researchers ... a vaccination is a normal and essential part of ... known in the U.S. as Tylenol -- after a shot ... some vaccines, transient fever means that a child,s immune system ...
... ... Meeting , ... (Vocus) October 16, 2009 -- An injured Iraqi citizen, a port wine stain patient, ... Patients of Courage: Triumph Over Adversity awards by the American Society of Plastic Surgeons (ASPS) ...
... , News facts: , October, ... individuals with breast cancer, however the experiences of those living ... the disease, is rarely discussed., MBC, also known as ... cancer has spread beyond the breast to other parts of ...
Cached Medicine News:Health News:Invasive Fungal Infections in HSCT Recipients: Improving Outcomes Through Prevention and Treatment 2Health News:Loss of tumor-suppressor and DNA-maintenance proteins causes tissue demise 2Health News:Acetaminophen May Weaken Effectiveness of Kids' Vaccines 2Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 2Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 3Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 4Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 2Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: